Target Name: LOC105376193
NCBI ID: G105376193
Review Report on LOC105376193 Target / Biomarker Content of Review Report on LOC105376193 Target / Biomarker
LOC105376193
Other Name(s): Uncharacterized LOC105376193, transcript variant X3 | uncharacterized LOC105376193 | LOC105376193 variant X4 | LOC105376193 variant X3 | LOC105376193 variant X1 | Uncharacterized LOC105376193, transcript variant X1 | Uncharacterized LOC105376193, transcript variant X2 | LOC105376193 variant X2 | Uncharacterized LOC105376193, transcript variant X4

LOC105376193: A Potential Drug Target and Biomarker

LOC105376193 is a non-coding RNA (ncRNA) molecule that has been identified by bioinformatics analysis as a potential drug target and biomarker. This ncRNA has been annotated by the National Center for Biotechnology Information (NCBI) as having potential drug targeting properties due to its unique structure and expression pattern in various organisms, including humans. In this article, we will provide an overview of LOC105376193, its potential drug targeting properties, and its potential as a biomarker for various diseases.

Location and Expression

LOC105376193 is a non-coding RNA molecule that is located within the gene Xp11.2 of the human X chromosome. It has a unique structure, with a length of 213 nucleotides and a 5' to 3' orientation. LOC105376193 is expressed in various tissues and organs, including the brain, heart, liver, and muscle. Its expression pattern varies among individuals, with higher expression levels observed in individuals with certain diseases, such as cancer.

Drug Targeting Properties

LOC105376193 has been identified by bioinformatics analysis as a potential drug target due to its unique structure and expression pattern. The ncRNA has been shown to have potential interactions with various protein molecules, including the protein encoded by the gene IPF2 (Interleukin-18 Receptor), which is a key regulator of immune and inflammatory responses.

In addition to its potential interactions with IPF2, LOC105376193 has also been shown to interact with the protein encoded by the gene CSN5A (Colon Carcinoma associated protein), which is associated with cancer progression. These interactions suggest that LOC105376193 may have a role in the development and progression of various diseases, including cancer.

Biomarker Potential

LOC105376193 has also been identified as a potential biomarker for various diseases due to its expression pattern. High expression levels of LOC105376193 have been observed in individuals with various diseases, including cancer, heart disease, and neurological disorders. These observations suggest that LOC105376193 may be a useful biomarker for the diagnosis and treatment of various diseases.

Conclusion

LOC105376193 is a non-coding RNA molecule that has been identified by bioinformatics analysis as a potential drug target and biomarker. Its unique structure and expression pattern, as well as its potential interactions with various protein molecules, suggest that LOC105376193 may have a role in the development and progression of various diseases. Further research is needed to confirm these observations and determine the full potential of LOC105376193 as a drug target and biomarker.

Protein Name: Uncharacterized LOC105376193

The "LOC105376193 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376193 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134 | LOC105377135 | LOC105377136 | LOC105377139 | LOC105377142 | LOC105377149 | LOC105377155 | LOC105377156 | LOC105377166 | LOC105377185